$14.86
-0.14-0.93%
Last update: Nov 6, 7:21 PM
Lyell Immunopharma Inc (LYEL) Stock Price, Quote, News & History
LYELNASDAQ
Lyell Immunopharma reports improved safety data for LYL273 in metastatic colorectal cancer and advances study to Phase 1/2 design.
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Other companies in Lyell Immunopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Lyell Immunopharma has a consensus price target of $31.63.
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $14.86 last updated November 6, 2026 at 7:21 PM EST.
There are no upcoming dividends for Lyell Immunopharma.
Lyell Immunopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Lyell Immunopharma.
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors....
